Two US scientists awarded Balzan Prize for cancer research

September 11, 2017 by Colleen Barry
Salvatore Veca attends a press conference to present a 2017 Balzan's prize edition, in Milan, Italy, Monday, Sept. 11, 2017. James Allison of the University of Texas MD Anderson Cancer Center and Robert Schreiber of the Washington School of Medicine were announced Monday as winners of the 750,000 Swiss franc (660,000 euro, $790,000) prize. They were cited for work that has helped use antibody treatments that has increased the survival of patients with metastic melanoma. (AP Photo/Antonio Calanni)

Two U.S. scientists whose work has contributed to creating immunological treatments for cancer are among the winners of this year's Balzan Prizes, announced Monday, recognizing scholarly and scientific achievements.

James Allison of the University of Texas MD Anderson Cancer Center and Robert Schreiber of the Washington University School of Medicine were cited for their work on antibody treatments that has increased the survival of patients with metastatic melanoma.

The Balzan Foundation awards two prizes in the sciences and two in the humanities each year, rotating specialties to highlight new or emerging areas of research and sustain fields that might be overlooked elsewhere. Recipients receive 750,000 Swiss francs ($790,000), half of which must be used for research, preferably by young scholars or scientists.

Nobel Prize-winner Jules Hoffman, a presenter of the awards, said the work focusing on using the immune system to fight cancer, expanding from the traditional treatments of removal, radiation and chemotherapy, has already had success in 25 to 30 percent of melanoma patients in a study who had previously gone through the traditional battery of treatments. It is now being developed for small cell lung cancer and rectal cancer.

Other winners are:

—Belgian astrophysicist Michael Gillon for his work that has helped map new solar systems from the comfort of planet Earth, using robotic telescopes instead of much more costly satellites.

Thomas Maissen speaks to journalists during a press conference to present a 2017 Balzan's prize edition, in Milan, Italy, Monday, Sept. 11, 2017. James Allison of the University of Texas MD Anderson Cancer Center and Robert Schreiber of the Washington School of Medicine were announced Monday as winners of the 750,000 Swiss franc (660,000 euro, $790,000) prize. They were cited for work that has helped use antibody treatments that has increased the survival of patients with metastic melanoma. (AP Photo/Antonio Calanni)

—Germans Aleida and Jan Assmann, a married couple recognized for their work presenting collective memory "as a requirement for the formation of the identity of religious and political communities."

—Indian economist Bina Agarwal, a professor at the University of Manchester, recognized in the gender studies category for her "heroic" work studying women's contributions to agriculture in India.

—This year, the Balzan Foundation also awarded a fifth prize, in international relations, which was deferred from last year after the committee failed to reach agreement on a winner. It went to Robert O. Keohane of the Woodrow Wilson School at Princeton University, best known for his influential 1984 book "After Hegemony: Cooperation and Discord in the World Political Economy."

Prizes will be awarded in Bern, Switzerland, on Nov. 17.

Explore further: 1 Japanese, 2 Americans win Crafoord science prize

Related Stories

1 Japanese, 2 Americans win Crafoord science prize

January 12, 2017
A Japanese and two American scientists have been awarded the 2017 Crafoord Prize for fundamental discoveries in immune regulation.

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.